Miyuki Nomura
Natori-shi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
The iron-sulfur cluster assembly factor FDX2 is required for tumor initiation but not for growth of established tumors in transplantation models.
Journal: The Journal of biological chemistry
Published: October 10, 2025
FDX2, an iron-sulfur cluster assembly factor, is essential to prevent cellular senescence, apoptosis or ferroptosis of ovarian cancer cells.
Journal: The Journal of biological chemistry
Published: April 17, 2024
Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma.
Journal: Nature communications
Published: April 18, 2023
Bird's eye view analysis of in situ cholesterol metabolic pathways in breast cancer patients and its clinicopathological significance in their subtypes.
Journal: The Journal of steroid biochemistry and molecular biology
Published: February 02, 2022
Ppp6c deficiency accelerates K-rasG12D -induced tongue carcinogenesis.
Journal: Cancer medicine
Published: December 07, 2020
Ppp6c haploinsufficiency accelerates UV-induced BRAF(V600E)-initiated melanomagenesis.
Journal: Cancer science
Published: October 16, 2020
Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: July 22, 2020
Comparison of the ischemic and non-ischemic lung cancer metabolome reveals hyper activity of the TCA cycle and autophagy.
Journal: Biochemical and biophysical research communications
Published: June 30, 2020
Novel activating KRAS mutation candidates in lung adenocarcinoma.
Journal: Biochemical and biophysical research communications
Published: October 31, 2019
Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancer.
Journal: FEBS letters
Published: September 03, 2019
Last Updated: 09/26/2026